How to manage hyponatremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hyponatremia with Sodium Level of 132 mEq/L

For mild hyponatremia with a sodium level of 132 mEq/L, monitoring and fluid restriction to 1,000 mL/day is the recommended approach, as this level falls within the mild category (126-135 mEq/L) that typically does not require specific intervention beyond careful observation. 1, 2

Assessment of Hyponatremia Severity and Etiology

Hyponatremia severity is classified as:

  • Mild: 126-135 mEq/L (current case at 132 mEq/L)
  • Moderate: 120-125 mEq/L
  • Severe: <120 mEq/L 1, 2, 3

Before initiating treatment, determine:

  1. Volume status - critical for determining etiology:

    • Hypovolemic: Signs include orthostatic hypotension, dry mucous membranes, tachycardia
    • Euvolemic: Normal vital signs, no edema
    • Hypervolemic: Edema, ascites, elevated JVP 2
  2. Chronicity:

    • Acute (<48 hours): More aggressive correction may be warranted
    • Chronic (>48 hours): Requires more cautious correction 1
  3. Symptomatology:

    • Mild symptoms: Nausea, headache, mild confusion
    • Severe symptoms: Seizures, coma, respiratory distress 3, 4

Management Algorithm for Sodium Level of 132 mEq/L

Step 1: Determine if intervention is needed

  • At 132 mEq/L, this is classified as mild hyponatremia
  • If asymptomatic, active intervention beyond monitoring may not be necessary 1, 2

Step 2: Identify and address underlying cause

Based on volume status:

  1. If hypovolemic:

    • Discontinue diuretics and/or laxatives if applicable
    • Provide fluid resuscitation with isotonic saline (0.9% NaCl) 1, 3
  2. If euvolemic:

    • Consider SIADH evaluation
    • Implement fluid restriction to 1,000 mL/day 1, 2
    • For persistent or symptomatic cases, consider urea, demeclocycline, or tolvaptan (for short-term use ≤30 days) 1, 5
  3. If hypervolemic (e.g., cirrhosis, heart failure):

    • Fluid restriction to 1,000 mL/day
    • Reduce or discontinue diuretics temporarily
    • Consider albumin infusion if cirrhosis-related 1

Special Considerations

For Cirrhotic Patients

  • Hyponatremia in cirrhosis reflects worsening hemodynamic status
  • Even modest hyponatremia (131-135 mEq/L) increases risk of complications including hepatic encephalopathy, hepatorenal syndrome, and spontaneous bacterial peritonitis 1
  • Albumin infusion may improve hyponatremia in hospitalized cirrhotic patients 1

For Neurosurgical Patients

  • Higher risk of complications from both hyponatremia and its correction
  • Differentiate between SIADH and cerebral salt wasting
  • Avoid fluid restriction in subarachnoid hemorrhage patients at risk of vasospasm 1

Cautions and Pitfalls

  1. Avoid overly rapid correction:

    • Do not exceed correction of 10 mEq/L in 24 hours (lower limit of 8 mEq/L recommended for high-risk patients) 1, 6
    • Rapid correction risks osmotic demyelination syndrome (ODS), especially in:
      • Patients with severe hyponatremia (<115 mEq/L)
      • Alcoholism
      • Malnutrition
      • Liver disease
      • Hypokalemia 6
  2. Monitor response to therapy:

    • Check serum sodium levels regularly during correction
    • If correction occurs too rapidly, consider administering electrolyte-free water or desmopressin 1
  3. Medication considerations:

    • When using tolvaptan, monitor for hypernatremia and overly rapid correction 5
    • Avoid grapefruit juice with tolvaptan due to CYP3A interactions 5

For a sodium level of 132 mEq/L without symptoms, the most appropriate approach is typically monitoring and mild fluid restriction, while addressing any underlying causes based on volume status assessment.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.